Edition:
India

Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

38.48USD
18 Sep 2020
Change (% chg)

$-1.19 (-3.00%)
Prev Close
$39.67
Open
$39.60
Day's High
$39.96
Day's Low
$38.40
Volume
4,771,400
Avg. Vol
2,135,333
52-wk High
$46.25
52-wk Low
$24.10

Latest Key Developments (Source: Significant Developments)

Boston Scientific Announces Q2 Gaap Loss Per Share $0.11
Wednesday, 29 Jul 2020 

July 29 (Reuters) - Boston Scientific Corp ::BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR SECOND QUARTER 2020.Q2 GAAP LOSS PER SHARE $0.11.Q2 SALES $2.003 BILLION VERSUS REFINITIV IBES ESTIMATE OF $1.73 BILLION.Q2 EARNINGS PER SHARE ESTIMATE $-0.02 -- REFINITIV IBES DATA.Q2 ADJUSTED EARNINGS PER SHARE $0.08.QTRLY CARDIOVASCULAR SEGMENT SALES $834 MILLION VERSUS $1026 MILLION.COMPANY DID NOT PROVIDE Q2 SALES AND EPS GUIDANCE.  Full Article

Boston Scientific Says Entered Into Second Amendment To $1 Billion 364-Day Term Loan Credit Agreement
Saturday, 30 May 2020 

May 29 (Reuters) - Boston Scientific Corp ::BOSTON SCIENTIFIC - ON MAY 28 ENTERED INTO SECOND AMENDMENT TO ITS $1 BILLION 364-DAY TERM LOAN CREDIT AGREEMENT.BOSTON SCIENTIFIC - AMENDED LIMITATION TO PERMIT PAYMENT OF QTRLY CASH DIVIDENDS, LIMITED CASH PAYMENTS ON CO'S 5.50% MANDATORY CONVERTIBLE PREFERRED STOCK.  Full Article

Boston Scientific Announces Offerings Of Common Stock And Mandatory Convertible Preferred Stock
Thursday, 21 May 2020 

May 20 (Reuters) - Boston Scientific Corp ::BOSTON SCIENTIFIC ANNOUNCES OFFERINGS OF COMMON STOCK AND MANDATORY CONVERTIBLE PREFERRED STOCK.BOSTON SCIENTIFIC CORP - COMMENCED CONCURRENT OFFERINGS OF $750.0 MILLION OF SHARES OF ITS COMMON STOCK.BOSTON SCIENTIFIC CORP - COMMENCED CONCURRENT OFFERINGS OF $750.0 MILLION OF SHARES OF ITS SERIES A MANDATORY CONVERTIBLE PREFERRED STOCK.  Full Article

Boston Scientific Files For Potential Stock Shelf Offering Size Not Disclosed
Thursday, 21 May 2020 

May 20 (Reuters) - Boston Scientific Corp ::BOSTON SCIENTIFIC CORP FILES FOR POTENTIAL STOCK SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILING.  Full Article

Boston Scientific Completes $1.7 Billion Offering Of Senior Notes
Tuesday, 19 May 2020 

Boston Scientific Corp ::BOSTON SCIENTIFIC COMPLETES $1.7 BILLION OFFERING OF SENIOR NOTES.  Full Article

Appaloosa Takes Share Stake Of 5.5 Million In Twitter Inc - SEC Filing
Saturday, 16 May 2020 

May 15 (Reuters) - APPALOOSA::APPALOOSA TAKES A SHARE STAKE OF 5.5 MILLION IN TWITTER INC - SEC FILING.APPALOOSA CUTS A SHARE STAKE BY 14.6% TO 2.4 MILLION CLASS A SHARES IN FACEBOOK - SEC FILING.APPALOOSA TAKES A SHARE STAKE OF 557,000 SHARES IN QUALCOMM- SEC FILING.APPALOOSA DISSOLVES SHARE STAKE IN CLEARWAY ENERGY INC- SEC FILING.APPALOOSA CUTS SHARE STAKE BY 18% IN ALPHABET TO 361,000 CLASS C SHARES - SEC FILING.APPALOOSA TAKES SHARE STAKE OF 115,000 SHARES IN BOSTON SCIENTIFIC CORP - SEC FILING.APPALOOSA - CHANGE IN HOLDINGS ARE AS OF MARCH 31, 2020 AND COMPARED WITH PREVIOUS QUARTER ENDED AS OF DEC. 31, 2019.  Full Article

Pinnacle FLX Study Of The Watchman FLX™ Left Atrial Appendage Closure Device Presented As Late-Breaking Clinical Trial At HRS 2020 Science
Friday, 8 May 2020 

May 8 (Reuters) - Boston Scientific Corp ::PINNACLE FLX STUDY OF THE WATCHMAN FLX™ LEFT ATRIAL APPENDAGE CLOSURE DEVICE PRESENTED AS LATE-BREAKING CLINICAL TRIAL AT HRS 2020 SCIENCE.BOSTON SCIENTIFIC - PINNACLE FLX TRIAL MEETS PRIMARY SAFETY AND EFFICACY ENDPOINTS WITH LOW COMPLICATION RATES.  Full Article

Boston Scientific Q1 GAAP EPS $0.01
Wednesday, 29 Apr 2020 

April 29 (Reuters) - Boston Scientific Corp ::BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FIRST QUARTER 2020.Q1 GAAP EARNINGS PER SHARE $0.01.Q1 SALES $2.543 BILLION VERSUS REFINITIV IBES ESTIMATE OF $2.52 BILLION.Q1 EARNINGS PER SHARE ESTIMATE $0.31 -- REFINITIV IBES DATA.Q1 ADJUSTED EARNINGS PER SHARE $0.28.UNABLE TO ESTIMATE OVERALL IMPACTS ON ITS OPERATIONS AND FINANCIAL RESULTS FOR REMAINDER OF 2020.QTRLY CARDIOVASCULAR SEGMENT SALES $1,026 MILLION VERSUS $972 MILLION REPORTED LAST YEAR.  Full Article

FDA Says It Has Identified Boston Scientific Corp's Imager II 5F Angiographic Catheters As A Class I Recall
Tuesday, 7 Apr 2020 

April 7 (Reuters) - FDA::FDA - HAS IDENTIFIED BOSTON SCIENTIFIC CORP'S IMAGER II 5F ANGIOGRAPHIC CATHETERS AS A CLASS I RECALL.FDA -BOSTON SCIENTIFIC IS RECALLING IMAGER II 5F ANGIOGRAPHIC CATHETERS BECAUSE THERE IS POTENTIAL FOR CATHETER TIP TO DETACH DURING PATIENT PROCEDURE.FDA - THERE ARE NINE REPORTED INJURIES FROM USE OF BOSTON SCIENTIFIC'S IMAGER II 5F ANGIOGRAPHIC CATHETERS.  Full Article

Boston Scientific Sees Q1 Organic Revenue Decline Of About 2 To 3 Percent
Thursday, 2 Apr 2020 

April 2 (Reuters) - Boston Scientific Corp ::BOSTON SCIENTIFIC CORP - FOR Q1 OF 2020, BUSINESS TRENDS THROUGH FIRST TWO MONTHS OF YEAR WERE IN LINE WITH COMPANY EXPECTATIONS.BOSTON SCIENTIFIC CORP - AS COVID-19 REACHED A GLOBAL PANDEMIC LEVEL IN MARCH, PROCEDURAL VOLUMES SIGNIFICANTLY DECLINED.BOSTON SCIENTIFIC CORP - EXPECTS Q1 2020 REVENUE GROWTH ON A GAAP BASIS TO BE APPROXIMATELY FLAT TO UP SLIGHTLY VERSUS PRIOR YEAR PERIOD.BOSTON SCIENTIFIC CORP SEES Q1 ORGANIC REVENUE DECLINE OF APPROXIMATELY TWO TO THREE PERCENT.BOSTON SCIENTIFIC CORP - OPTIMIZING APPROPRIATE VARIABLE COSTS, INCLUDING MANUFACTURING OUTPUT.BOSTON SCIENTIFIC CORP - SIGNIFICANTLY REDUCING SALARIES OF ITS CHIEF EXECUTIVE OFFICER, BOARD OF DIRECTORS AND EXECUTIVE COMMITTEE MEMBERS.BOSTON SCIENTIFIC CORP - WHERE APPROPRIATE, CO IS TEMPORARILY REDUCING WORK WEEK SCHEDULES FOR EMPLOYEES..  Full Article

UPDATE 3-Boston Scientific sees improved July trends as elective surgery recovers

July 29 Medical device maker Boston Scientific Corp on Wednesday posted a surprise adjusted quarterly profit and said demand for elective procedures picked up pace in July following an easing of coronavirus-driven restrictions.